Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Duquesne

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
European Urology|March 27, 2024
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder CancerIgor Duquesne, Alexandre de la Taille
Intractable & Rare Diseases Research|June 15, 2022
Intravesical MgSO<sub>4</sub> for the treatment of BCG refractory T1 G3 bladder cancer: Preliminary results on efficacy and safetyMohamad Moussa, Mohamad Abou Chakra, Igor Duquesne
World Journal of Urology|September 20, 2024
Letter to the editor for the article "Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach"Igor Duquesne, Dimitri Vordos, Alexandre de la Taille
Frontiers in Bioscience (Landmark Edition)|May 30, 2026
Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder CancerMohamad Abou Chakra, Igor Duquesne, Michael A O'Donnell
Journal of Clinical Medicine|August 11, 2019
Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic ReviewIgor Duquesne, Idir Ouzaid, Yohann Loriot, et al.
Frontiers in Bioscience (Landmark Edition)|August 29, 2024
Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder CancerMohamad Abou Chakra, Yi Luo, Igor Duquesne, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2015
In vitro evaluation and comparison of 5 rapid antigen detection tests for the diagnosis of beta-hemolytic group A streptococcal pharyngitisCéline Plainvert, Igor Duquesne, Gérald Touak, et al.
Expert Review of Anticancer Therapy|August 4, 2023
Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?Igor Duquesne, Mohamad Abou Chakra, Lory Hage, et al.
Translational Andrology and Urology|January 23, 2018
The contemporary role and impact of urine-based biomarkers in bladder cancerIgor Duquesne, Lars Weisbach, Atiqullah Aziz, et al.
Translational Andrology and Urology|December 10, 2025
Global insights into the management of BCG-unresponsive non-muscle invasive bladder cancer: a narrative review of provider surveysMohamad Abou Chakra, Igor Duquesne, Mahmoud Mima, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
European Urology|March 27, 2024
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder CancerIgor Duquesne, Alexandre de la Taille
Intractable & Rare Diseases Research|June 15, 2022
Intravesical MgSO<sub>4</sub> for the treatment of BCG refractory T1 G3 bladder cancer: Preliminary results on efficacy and safetyMohamad Moussa, Mohamad Abou Chakra, Igor Duquesne
World Journal of Urology|September 20, 2024
Letter to the editor for the article "Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach"Igor Duquesne, Dimitri Vordos, Alexandre de la Taille
Frontiers in Bioscience (Landmark Edition)|May 30, 2026
Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder CancerMohamad Abou Chakra, Igor Duquesne, Michael A O'Donnell
Journal of Clinical Medicine|August 11, 2019
Lymphadenectomy for Upper Tract Urothelial Carcinoma: A Systematic ReviewIgor Duquesne, Idir Ouzaid, Yohann Loriot, et al.
Frontiers in Bioscience (Landmark Edition)|August 29, 2024
Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder CancerMohamad Abou Chakra, Yi Luo, Igor Duquesne, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2015
In vitro evaluation and comparison of 5 rapid antigen detection tests for the diagnosis of beta-hemolytic group A streptococcal pharyngitisCéline Plainvert, Igor Duquesne, Gérald Touak, et al.
Expert Review of Anticancer Therapy|August 4, 2023
Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?Igor Duquesne, Mohamad Abou Chakra, Lory Hage, et al.
Translational Andrology and Urology|January 23, 2018
The contemporary role and impact of urine-based biomarkers in bladder cancerIgor Duquesne, Lars Weisbach, Atiqullah Aziz, et al.
Translational Andrology and Urology|December 10, 2025
Global insights into the management of BCG-unresponsive non-muscle invasive bladder cancer: a narrative review of provider surveysMohamad Abou Chakra, Igor Duquesne, Mahmoud Mima, et al.
Pageof 6